Clinical Trial Update: Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating hydroxychloroquine for metabolic outcomes in patients undergoing TPAIT (transplant pancreatic islet auto/allo? - not specified).…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Dependent Diabetes
• Pancreatitis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Chronic Pancreatitis, Insulin Dependent Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2022-03-11